IBREXAFUNGERP for Vulvovaginal candidiasis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where IBREXAFUNGERP was used for Vulvovaginal candidiasis.
Most Reported Side Effects for IBREXAFUNGERP
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 31 | 24.0% | 3 | 3 |
| Diarrhoea | 26 | 20.2% | 0 | 0 |
| Nausea | 22 | 17.1% | 0 | 0 |
| Recalled product administered | 20 | 15.5% | 0 | 1 |
| Vomiting | 13 | 10.1% | 0 | 2 |
| Therapeutic product effect incomplete | 10 | 7.8% | 0 | 0 |
| Dizziness | 9 | 7.0% | 0 | 2 |
| Product dispensing error | 9 | 7.0% | 0 | 0 |
| Abdominal pain | 7 | 5.4% | 0 | 0 |
| Off label use | 7 | 5.4% | 1 | 1 |
| Abdominal pain upper | 6 | 4.7% | 0 | 0 |
| Rash | 6 | 4.7% | 0 | 0 |
| Condition aggravated | 5 | 3.9% | 0 | 0 |
| Pruritus | 5 | 3.9% | 0 | 0 |
Other Indications for IBREXAFUNGERP
Product used for unknown indication (53)
Vulvovaginal mycotic infection (21)
Fungal infection (16)
Candida infection (12)
Other Drugs Used for Vulvovaginal candidiasis
FLUCONAZOLE (398)
CLOTRIMAZOLE (37)
ITRACONAZOLE (26)
OTESECONAZOLE (14)
MICONAZOLE (9)
ECONAZOLE (8)
REZAFUNGIN (7)
NYSTATIN (5)